Abstract
There is little information regarding the clinical performance of hip resurfacing arthroplasty (HRA) in older patients. Eighty-seven patients (99 hips) aged 65 years or older received HRA while a control group of 52 patients (64 hips) received a primary THA. The average age was 69.2 years for the HRA group and 71.9 years for the THA group. Follow-up ranged from 2 to 13 years. UCLA walking, function and activity scores and SF-12 scores were higher in the HRA group. At 10 years, the Kaplan-Meier overall survivorship rates were 96.7% for the HRA group and 91.2% for the THA group (p = 0.3174). We suggest considering hip resurfacing for patients 65 or older in centres where there is expertise in performing this procedure.
Get full access to this article
View all access options for this article.
